๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Zoledronic acid is superior to pamidronate in patients with breast cancer and bone metastases

โœ Scribed by L. Rosen; R. Coleman; D. Gordon; P. Major; M. Kaminski; J. Apffelstaedt; A. Howell; B.L. Chen; J. Seaman

Book ID
114315663
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
402 KB
Volume
12
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Zoledronic acid is superior to pamidrona
Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion
โœ Lee S. Rosen; David H. Gordon; William Dugan Jr.; Pierre Major; Peter D. Eisenbe ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 131 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND Treatment with zoledronic acid (Zol) was compared with a dose of 90 mg of pamidronate (Pam) in breast carcinoma (BC) patients with at least 1 osteolytic lesion based on data from a Phase III, randomized trial. ## METHODS Overall, 1130 patients with breast carcinoma who